TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Australian Clinical Labs Ltd ( (AU:ACL) ) has issued an update.
Australian Clinical Labs Limited has announced an update regarding their on-market buy-back of ordinary fully paid securities, with a total of 199,627 securities bought back on the previous day. This buy-back initiative is part of the company’s strategy to manage its capital structure, potentially enhancing shareholder value and signaling confidence in its financial health.
The most recent analyst rating on (AU:ACL) stock is a Hold with a A$3.00 price target. To see the full list of analyst forecasts on Australian Clinical Labs Ltd stock, see the AU:ACL Stock Forecast page.
More about Australian Clinical Labs Ltd
Australian Clinical Labs Limited operates in the healthcare industry, providing pathology services and diagnostic testing. The company focuses on delivering high-quality laboratory services to support medical professionals and patients across Australia.
Average Trading Volume: 1,018,000
Technical Sentiment Signal: Sell
Current Market Cap: A$511M
See more data about ACL stock on TipRanks’ Stock Analysis page.